Funding Rounds
Invitris

Invitris April 2023 Pre-Seed Funding Round

Invitris

Invitris is a protein-based drugs founded in 2022 by Patrick Grossmann.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Pre Seed

Raised Amount: $0.50M

Raised Date: 2023-04-05

Investors